Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview.

Caciotti A, Melani F, Tonin R, Cellai L, Catarzi S, Procopio E, Chilleri C, Mavridou I, Michelakakis H, Fioravanti A, d'Azzo A, Guerrini R, Morrone A.

Mol Genet Metab. 2019 Oct 31. pii: S1096-7192(19)30537-2. doi: 10.1016/j.ymgme.2019.09.005. [Epub ahead of print] Review.

PMID:
31711734
2.

Occurrence and repair of alkylating stress in the intracellular pathogen Brucella abortus.

Poncin K, Roba A, Jimmidi R, Potemberg G, Fioravanti A, Francis N, Willemart K, Zeippen N, Machelart A, Biondi EG, Muraille E, Vincent SP, De Bolle X.

Nat Commun. 2019 Oct 24;10(1):4847. doi: 10.1038/s41467-019-12516-8.

3.

MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway.

Cheleschi S, Gallo I, Barbarino M, Giannotti S, Mondanelli N, Giordano A, Tenti S, Fioravanti A.

Int J Mol Sci. 2019 Oct 20;20(20). pii: E5200. doi: 10.3390/ijms20205200.

4.

A retrospective observational study of glucosamine sulfate in addition to conventional therapy in hand osteoarthritis patients compared to conventional treatment alone.

Tenti S, Giordano N, Mondanelli N, Giannotti S, Maheu E, Fioravanti A.

Aging Clin Exp Res. 2019 Aug 19. doi: 10.1007/s40520-019-01305-4. [Epub ahead of print]

PMID:
31429006
5.

MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes.

Cheleschi S, Tenti S, Mondanelli N, Corallo C, Barbarino M, Giannotti S, Gallo I, Giordano A, Fioravanti A.

Cells. 2019 Aug 11;8(8). pii: E874. doi: 10.3390/cells8080874.

6.

Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features.

Corallo C, Fioravanti A, Tenti S, Pecetti G, Nuti R, Giordano N.

Rheumatol Int. 2019 Oct;39(10):1767-1775. doi: 10.1007/s00296-019-04401-w. Epub 2019 Aug 1.

PMID:
31372720
7.

Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.

Corallo C, Pinto AM, Renieri A, Cheleschi S, Fioravanti A, Cutolo M, Soldano S, Nuti R, Giordano N.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):69-75. Epub 2019 Jul 19.

8.

Structure of S-layer protein Sap reveals a mechanism for therapeutic intervention in anthrax.

Fioravanti A, Van Hauwermeiren F, Van der Verren SE, Jonckheere W, Goncalves A, Pardon E, Steyaert J, De Greve H, Lamkanfi M, Remaut H.

Nat Microbiol. 2019 Nov;4(11):1805-1814. doi: 10.1038/s41564-019-0499-1. Epub 2019 Jul 15.

PMID:
31308522
9.

Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?

Corallo C, Cheleschi S, Cutolo M, Soldano S, Fioravanti A, Volpi N, Franci D, Nuti R, Giordano N.

Arthritis Res Ther. 2019 Jun 24;21(1):152. doi: 10.1186/s13075-019-1931-x.

10.

Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.

Bernetti A, Mangone M, Villani C, Alviti F, Valeo M, Grassi MC, Migliore A, Viora U, Adriani E, Quirino N, Fioravanti A, Paoloni M.

Eur J Phys Rehabil Med. 2019 Oct;55(5):658-664. doi: 10.23736/S1973-9087.19.05633-8. Epub 2019 May 15.

11.

Elevated serum levels of alarmin S100A8/A9 in patients with hand osteoarthritis.

Addimanda O, Pulsatelli L, Vogl T, Roth J, Mancarella L, Assirelli E, Ramonda R, Fioravanti A, Meliconi R.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):885. Epub 2019 May 7. No abstract available.

12.

Exploring the Involvement of NLRP3 and IL-1β in Osteoarthritis of the Hand: Results from a Pilot Study.

Fioravanti A, Tenti S, McAllister M, Chemaly M, Eakin A, McLaughlin J, Bjourson AJ, Frati E, McGilligan V, Cheleschi S, Gibson DS.

Mediators Inflamm. 2019 Mar 10;2019:2363460. doi: 10.1155/2019/2363460. eCollection 2019.

13.

Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature.

Tenti S, Giordano N, Cutolo M, Giannini F, Fioravanti A.

Medicine (Baltimore). 2019 Mar;98(13):e15052. doi: 10.1097/MD.0000000000015052. Review.

14.

CD25 deficiency: A new conformational mutation prevents the receptor expression on cell surface.

Vignoli M, Ciullini Mannurita S, Fioravanti A, Tumino M, Grassi A, Guariso G, Favre C, D'Elios MM, Gambineri E.

Clin Immunol. 2019 Apr;201:15-19. doi: 10.1016/j.clim.2019.02.003. Epub 2019 Feb 8.

PMID:
30742970
15.

NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.

Marampon F, Codenotti S, Megiorni F, Del Fattore A, Camero S, Gravina GL, Festuccia C, Musio D, De Felice F, Nardone V, Santoro AN, Dominici C, Fanzani A, Pirtoli L, Fioravanti A, Tombolini V, Cheleschi S, Tini P.

J Cancer Res Clin Oncol. 2019 Apr;145(4):881-893. doi: 10.1007/s00432-019-02851-0. Epub 2019 Jan 30.

PMID:
30701326
16.

Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations.

Elena C, Chiara M, Angelica B, Chiara MA, Laura N, Chiara C, Claudio C, Antonella F, Nicola G.

Curr Pharm Biotechnol. 2018;19(15):1210-1220. doi: 10.2174/1389201020666190102145305. Review.

PMID:
30605054
17.

A Complex Relationship between Visfatin and Resistin and microRNA: An In Vitro Study on Human Chondrocyte Cultures.

Cheleschi S, Giordano N, Volpi N, Tenti S, Gallo I, Di Meglio M, Giannotti S, Fioravanti A.

Int J Mol Sci. 2018 Dec 6;19(12). pii: E3909. doi: 10.3390/ijms19123909.

18.

In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis.

Cheleschi S, Calamia V, Fernandez-Moreno M, Biava M, Giordani A, Fioravanti A, Anzini M, Blanco F.

Int Immunopharmacol. 2018 Nov;64:86-100. doi: 10.1016/j.intimp.2018.08.025. Epub 2018 Aug 25.

PMID:
30153531
19.

Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.

Fioravanti A, Tenti S, Bacarelli MR, Damiani A, Li Gobbi F, Bandinelli F, Cheleschi S, Galeazzi M, Benucci M.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):293-300. Epub 2018 Aug 27.

20.

Effects of balneotherapy and spa therapy on quality of life of patients with knee osteoarthritis: a systematic review and meta-analysis.

Antonelli M, Donelli D, Fioravanti A.

Rheumatol Int. 2018 Oct;38(10):1807-1824. doi: 10.1007/s00296-018-4081-6. Epub 2018 Jun 12.

PMID:
29947999

Supplemental Content

Loading ...
Support Center